机构：[1]Lung Cancer Center/Lung Cancer Institute,West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[2]Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China[3]Department of Pathology,West China Hospital, Sichuan University, Chengdu, China四川大学华西医院[4]Department of Radiology, Tianjin Medical University General Hospital, Tianjin, China[5]Department of Diagnostic Radiology, Cancer Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China[6]Department of Thoracic Cardiovascular Surgery, The Third Affiliated Hospital of Kunming Medical College (Yunnan Tumor Hospital), Kunming, China[7]Department of Endoscopy, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College, Beijing, China[8]Department of Pathology, Tianjin Medical University General Hospital, Tianjin, China[9]Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Lung cancer is the leading cause of cancer-related death in China. Results from a randomized controlled trial using annual low-dose computed tomography (LDCT) in specific high-risk groups demonstrated a 20% reduction in lung cancer mortality.
A China national lung cancer screening guideline was developed by lung cancer early detection and treatment expert group appointed by the National Health and Family Planning Commission, based on results of the National Lung Screening Trial, systematic review of evidence related to LDCT screening, and protocol of lung cancer screening program conducted in rural China.
Annual lung cancer screening with LDCT is recommended for high risk individuals aged 50-74 years who have at least a 20 pack-year smoking history and who currently smoke or have quit within the past five years. Individualized decision making should be conducted before LDCT screening. LDCT screening also represents an opportunity to educate patients as to the health risks of smoking; thus, education should be integrated into the screening process in order to assist smoking cessation.
A lung cancer screening guideline is provided for the high-risk population in China.
基金：
This study was partly supported by the grants from the
National High Technology Research and Development of
China (No. 2012AA02A502) and National Project of Lung
Cancer Early Diagnosis and Treatment of China (No.
201501002-1), the National Eleventh-Five-Year Key Task
Projects of China (No.2006BAI02A01), and the China-
Sweden International Scientific and Technological Cooperative
Project (No. 09ZCDSF04100).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2015]版：
大类|4 区医学
小类|4 区肿瘤学4 区呼吸系统
最新[2023]版：
大类|3 区医学
小类|4 区肿瘤学4 区呼吸系统
第一作者：
第一作者机构：[1]Lung Cancer Center/Lung Cancer Institute,West China Hospital, Sichuan University, Chengdu, China[2]Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China[*1]Sichuan Lung Cancer Center/Lung Cancer Institute,West China Hospital, Sichuan University, No. 37, Guo Xue Xiang,Wuhou District, Chengdu, Sichuan 610041, China[*2]Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, No.154, Anshan Street, Tianjin 300052, China.
共同第一作者：
通讯作者：
通讯机构：[1]Lung Cancer Center/Lung Cancer Institute,West China Hospital, Sichuan University, Chengdu, China[2]Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Tianjin, China[9]Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China[*1]Sichuan Lung Cancer Center/Lung Cancer Institute,West China Hospital, Sichuan University, No. 37, Guo Xue Xiang,Wuhou District, Chengdu, Sichuan 610041, China[*2]Tianjin Key Laboratory of Lung Cancer Metastasis and Tumor Microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, No.154, Anshan Street, Tianjin 300052, China.[*3]Department of Cancer Epidemiology, Cancer Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 South, Panjiayuan Lane, Beijing 10021, China.
推荐引用方式(GB/T 7714)：
Qing-hua Zhou,Ya-guang Fan,Hong Bu,et al.China national lung cancer screening guideline with low-dose computed tomography (2015 version).[J].Thoracic cancer.2015,6(6):812-8.doi:10.1111/1759-7714.12287.
APA：
Qing-hua Zhou,Ya-guang Fan,Hong Bu,Ying Wang,Ning Wu...&You-lin Qiao.(2015).China national lung cancer screening guideline with low-dose computed tomography (2015 version)..Thoracic cancer,6,(6)
MLA：
Qing-hua Zhou,et al."China national lung cancer screening guideline with low-dose computed tomography (2015 version).".Thoracic cancer 6..6(2015):812-8
